DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING

被引：1
|
作者：
Waxman, Aaron
Nathan, Steven
Fisher, Micah
Ford, H. James
Gagermeier, James
Parambil, Joseph
Raina, Amresh
Zwicke, Dianne
Gerke, Alicia
Shen, Eric
Lee, Dasom
Rao, Youlan
Tapson, Victor
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1995
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2279A / 2280A
页数：2
相关论文
共 50 条
  • [1] Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
    Nathan, Steven D.
    Deng, Chunqin
    King, Christopher S.
    DuBrock, Hilary M.
    Elwing, Jean
    Rajagopal, Sudarshan
    Rischard, Franz
    Sahay, Sandeep
    Broderick, Meredith
    Shen, Eric
    Smith, Peter
    Tapson, Victor F.
    Waxman, Aaron B.
    [J]. CHEST, 2023, 163 (02) : 398 - 406
  • [2] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Response
    Nathan, Steven D.
    Shen, Eric
    Deng, Chunqin
    [J]. CHEST, 2024, 165 (05) : e162 - e162
  • [3] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    [J]. CHEST, 2021, 160 (04) : 2244A - 2246A
  • [4] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [5] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Genecand, Leon
    Lador, Frederic
    Montani, David
    Perneger, Thomas
    [J]. CHEST, 2024, 165 (05) : e161 - e161
  • [6] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    [J]. LUNG, 2018, 196 (02) : 139 - 146
  • [7] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    [J]. Lung, 2018, 196 : 139 - 146
  • [8] Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
    Behr, Juergen
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 144 - 146
  • [9] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease
    Sakao, Seiichiro
    Kondoh, Yasuhiro
    Kinoshita, Hideyuki
    Nishiyama, Osamu
    Ogo, Takeshi
    Tanabe, Nobuhiro
    Minatsuki, Shun
    Nakayama, Kazuhiko
    Taniguchi, Yu
    Takahashi, Kenta
    Takatsu, Masahiro
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (06) : 980 - 986
  • [10] The Effect of Subcutaneous Treprostinil on Pulmonary Hypertension Associated with Interstitial Lung Disease
    Sadushi-Kolici, Roela
    Shafran, Inbal
    Prosch, Helmut
    Skoro-Sajer, Nika
    Gerges, Christin
    Lang, Irene
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345